Weakly positive tests and chronologic variation of the QuantiFERON assay: A retrospective appraisal of usefulness

Tuberculosis

Volumn 93, Issue 6, 2013, Pages 647-653

  Felber, Anja ^a   Graninger, Winfried ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Anti TNF therapy; Immunosuppression; QuantiFERON; Test reproducibility

Indexed keywords

ABATACEPT; GAMMA INTERFERON; RITUXIMAB; TOCILIZUMAB; TUBERCULOSTATIC AGENT;

ARTICLE; AUTOIMMUNE DISEASE; COHORT ANALYSIS; CONFUSION; CONTROLLED STUDY; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DISEASE DURATION; HUMAN; IMMUNOREACTIVITY; INTERFERON GAMMA RELEASE ASSAY; LABORATORY DIAGNOSIS; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MYCOBACTERIUM TUBERCULOSIS; OUTPATIENT; PRIORITY JOURNAL; REPRODUCIBILITY; RETROSPECTIVE STUDY; THORAX RADIOGRAPHY; TUBERCULOSIS;

ANTI-TNF-Α-THERAPY; IMMUNOSUPPRESSION; QUANTIFERON; TEST REPRODUCIBILITY;

ANTIGENS, BACTERIAL; AUTOIMMUNE DISEASES; FALSE POSITIVE REACTIONS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-GAMMA; INTERFERON-GAMMA RELEASE TESTS; LATENT TUBERCULOSIS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; TUBERCULOSIS, PULMONARY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84887405833     PISSN: 14729792     EISSN: 1873281X     Source Type: Journal    
DOI: 10.1016/j.tube.2013.07.006     Document Type: Article

References (46)

1. V. Bordignon, S. Bultrini, G. Prignano, I. Sperduti, G. Piperno, C. Bonifati, M. Filippetti, L. Toma, A. Latini, M. di Cecio, A. Giuliani, A. Vocaturo, E. Trento, G. D'Agosto, F. Francesconi, A. Cataldo, A. Vento, V. Clienti, E. Berardesca, F. Ameqlio, P. Cordiali Fei, and F. Ensoli High prevalence of latent tuberculosis infection in autoimmune disorders such as psoriasis and in chronic respiratory diseases, including lung cancer J Biol Regul Homeost Agents 25 2011 213 220
2. A. Nienhaus, A. Schablon, D. Tripoldi, and J. Torres Costa The prevalence of latent tuberculosis infections among health-care workers - a three country comparison Pneumologie 65 2011 726 729
3. H.E. Kaufmann, and P. van Helden Handbook of tuberculosis - clinics, diagnostics, therapy and epidemiology 2008 Wiley-VCH Weinheim
4. B.P. Linas, A.Y. Wong, K.A. Freedberg, and C.R. Horsburgh Jr. Priorities for screening and treatment of latent tuberculosis infection in the United States Am J Respir Crit Care Med 184 2011 590 601
5. J.Y. Lee, H.J. Choi, I.N. Park, S.B. Hong, Y.M. Oh, C.M. Lim, S.D. Lee, Y. Koh, W.S. Kim, D.S. Kim, W.D. Kim, and T.S. Shim Comparison of two commercial interferon gamma assays for diagnosing Mycobacterium tuberculosis infection Eur Respir J 28 2006 24 30
6. I. Brock, K. Weldingh, E.M. Leyten, S.M. Arend, P. Ravn, and P. Andersen Specific T-cell epitopes for immunoassay-based diagnosis of M tuberculosis infection J Clin Microbiol 42 2004 2379 2387
7. T. Mori, M. Sakatani, F. Yamagishi, T. Takashima, Y. Kawabe, K. Nagao, E. Shigeto, N. Harada, S. Mitarai, M. Okada, K. Suzuki, Y. Inoue, K. Tsuyuguchi, Y. Sasaki, G.H. Mazurek, and I. Tsuyuguchi Specific detection of tuberculosis infection: an interferon gamma-based assay using new antigens Am J Respir Crit Care Med 170 2004 59 64
8. R.S. Wallis, M.S. Broder, J.Y. Wong, M.E. Hanson, and D.O. Beenhouwer Granulomatous infectious diseases associated with tumor necrosis factor antagonists Clin Infect Dis 38 2004 1261 1265
9. F. Wolfe, K. Michaud, J. Anderson, and K. Urbansky Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy Arthritis Rheum 50 2004 372 379
10. R. Gineys, B. Bodaghi, G. Carcelain, N. Cassoux, T.H. Boutin le, and Z. Amoura QuantiFERON-TB gold cut-off value: implications for the management of tuberculosis-related ocular inflammation Am J Ophthalmol 152 2011 433 440
11. S. Perry, L. Sanchez, S. Yang, Z. Agarwal, P. Hurst, and J. Parsonnet Reproducibility of QuantiFERON-TB gold in-tube assay Clin Vaccine Immunol 15 2008 425 432
12. F.C. Ringshausen, A. Nienhaus, A. Schablon, S. Schlösser, G. Schultze-Werninghaus, and G. Rohde Predictors of persistently positive Mycobacterium tuberculosis-specific interferon-gamma responses in the serial testing of health care workers BMC Infect Dis 10 2010 220
13. A. Schablon, M. Harling, R. Diel, F.C. Ringshausen, J. Torres Costa, and A. Nienhaus Serial testing with an interferon-gamma release assay in German health care workers GMS Krankenhyg Interdiszip 5 2010
14. J. Torres Costa, R. Silva, R. Sa, M.J. Cardoso, and A. Nienhaus Serial testing with the interferon-gamma release assay in Portuguese health care workers Int Arch Occup Environ Health 84 2011 461 469
15. M. Pai, and R. O'Brien Serial testing for tuberculosis: can we make sense of T-cell assay conversions and reversions? PLoS Med 4 2007 e208
16. R. Diel, R. Loddenkemper, K. Meywald-Walter, R. Gottschalk, and A. Nienhaus Comparative performance of tuberculin skin test, QuantiFERON-TB-Golg in Tube assay, and T-Spot. TB test in contact investigations for tuberculosis Chest 135 2009 1010 1018
17. S. Arend, S.F. Thijsen, E.M. Leyton, J.J. Bouwman, W.P. Franken, and B.F. Koster Comparison of two interferon-É£ assays and tuberculin skin test for tracing tuberculosis contacts Am J Respir Crit Care Med 175 2007 618 627
18. D.R. Chen, G.H. Shen, Y.M. Chen, H.H. Chen, C.W. Hsieh, and J.L. Jan Biphasic emergence of active tuberculosis in rheumatoid arthritis patients receiving TNFα inhibitors: the utility of IFNγ assay Ann Rheum Dis 71 2012 231 237
19. I. Casas, I. Latorre, M. Esteve, J. Ruiz-Manzano, D. Rodriguez, and C. Prat Evaluation of interferon-gamma release assays in the diagnosis of recent tuberculosis infection in health care workers PLoS ONE 4 2009 e6686
20. F. Bartalesi, S. Vicidomini, D. Goletti, C. Fiorelli, G. Fiori, D. Melchiorre, E. Tortoli, A. Mantella, M. Benucci, E. Girardi, M.M. Cerinic, and A. Bartoloni QuantiFERON TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases Eur Respir J 33 2009 586 593
21. F.C. Ringshausen, A. Nienhaus, J. Torres Costa, H. Knoop, S. Schlösser, G. Schultze-Werninghaus, and G. Rohde Within-subject variability of Mycobacterium tuberculosis-specific gamma interferon responses in German health care workers Clin Vaccine Immunol 18 2011 1176 1182
22. A. Veerapathran, R. Joshi, K. Goswami, S. Dogra, E.E. Moodie, M.V. Reddy, S. Kalantri, K. Schwartzman, M.A. Behr, D. Menzies, and M. Pai T-cell assays for tuberculosis infection: deriving cut-offs for conversions using reproducibility data PLoS One 3 2008 e1850
23. K.H. Kim, S.W. Lee, W.T. Chung, B.G. Kim, K.S. Woo, and J.Y. Han Serial interferon-gamma release assays for the diagnosis of latent tuberculosis infection in patients treated with immunosuppressive agents Korean J Lab Med 31 2011 271 278
24. M. Pai, R. Joshi, S. Dogra, D.K. Mendiratta, P. Narang, S. Kalantri, A.L. Reingold, J.M. Colford Jr., L.W. Riley, and D. Menzies Serial testing of health care workers for tuberculosis using interferon-gamma assay Am J Respir Crit Care Med 174 2006 349 355
25. K. Ewer, K.A. Millington, J.J. Deeks, L. Alvarez, G. Bryant, and A. Lalvani Dynamic antigen-specific T-cell responses after point-source exposure to M tuberculosis Am J Respir Crit Care Med 174 2006 831 839
26. D. Doberne, R.L. Gaur, and N. Banaei Preanalytical delay reduces sensitivity of QuantiFERON-TB gold in-tube assay for detection of latent tuberculosis infection J Clin Microbiol 49 2011 3061 3064
27. P.C. Hill, R.H. Brookes, A. Fox, D. Jackson-Sillah, D.J. Jeffries, M.D. Lugos, S.A. Donkor, I.M. Adetifa, B.C. de Jong, A.M. Aiken, R.A. Adegbola, and K.P. McAdam Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection PLoS Med 4 2007 e192
28. G. Ferrara, M. Losi, M. Meacci, B. Meccugni, R. Piro, P. Roversi, B.M. Bergamini, R. D'Amico, P. Marchegiano, F. Rumpianesi, L.M. Fabbri, and M. Richeldi Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infection Am J Respir Crit Care Med 172 2005 631 635
29. P. Ravn, M.E. Munk, A.B. Andersen, B. Lundgren, J.D. Lundgren, L.N. Nielsen, M. Filippetti, L. Toma, A. Latini, M. di Cecio, A. Giuliani, A. Vocaturo, E. Trento, G. D'Agosto, F. Francesconi, A. Cataldo, A. Vento, V. Clienti, E. Berardesca, F. Ameqlio, P. Cordiali Fei, and F. Ensoli Prospective evaluation of a whole blood test using Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10 for diagnosis of active tuberculosis Cli Diagn Lab Immunol 12 2005 491 496
30. C.B. Chee, S.H. Gan, K.W. Khinmar, T.M. Barkham, C.K. Koh, and S. Liang Comparison of sensitivities of two commercial gamma interferon release assays for pulmonary tuberculosis J Clin Microbiol 46 2008 1935 1940
31. R. Diel, B. Hauer, R. Loddenkemper, B. Manger, and K. Krüger Empfehlungen für das Tuberkulosescreening vor Gabe von TNF-α- Inhibitoren bei rheumatologischen Erkrankungen Pneumologie 63 2008 329 334
32. D. Vassilopoulos, S. Tsikrika, C. Hatzara, V. Podia, A. Kandili, and N. Stamoulis Comparison of two gamma interferon release assays and tuberculin skin testing for tuberculosis screening in a cohort of patients with rheumatic diseases starting anti-tumor necrosis factor therapy Clin Vaccine Immunol 18 2011 2102 2108
33. ® - TB gold results in a public health clinic setting Int J Tuberc Lung Dis 15 2011 1623 1630
34. R.D. Powell III, W.C. Whitworth, J. Bernado, P.K. Moonan, and G.H. Mazurek Unusual interferon gamma measurements with QuantiFERON-TB gold and QuantiFERON-TB gold in-tube tests PLoS One 6 2011 e20061
35. M. Pai, A. Zwerling, and D. Menzies Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update Ann Intern Med 149 2008 177 184
36. M. Pai, and D. Menzies Interferon-gamma-release assays: what is their role in the diagnosis of active tuberculosis? Clin Infect Dis 44 2007 74 77
37. D. Menzies Using tests for latent tuberculosis infection to diagnose active tuberculosis: can we eat our cake and have it too? Ann Intern Med 148 2008 398 399
38. K. Komiya, H. Ariga, H. Nagai, A. Kurashima, S. Shoji, and H. Ishii Reversion rates of QuantiFERON-TB Gold are related to pre-treatment IFN-gamma levels J Infect 63 2011 48 53
39. S. Ehlers Role of tumor necrosis factor (TNF) in host defence against tuberculosis: implications for immunotherapies targeting TNF Ann Rheum Dis 62 Suppl. 2 2003 ii37 ii42
40. G. Matulis, P. Jüni, P.M. Villiger, and S.D. Gadola Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon gamma assay Ann Rheum Dis 67 2008 84 90
41. A.F. Luetkemeyer, E.D. Charlebois, L.L. Flores, D.R. Bangsberg, S.G. Deeks, and J.N. Martin Comparison of an interferon-gamma release assay with tuberculin skin testing in HIV-infected individuals Am J Respir Crit Care Med 175 2007 737 742
42. S. Mankia, J.E. Peters, S. Kang, S. Moore, and M.R. Ehrenstein Tuberculosis and anti-TNF treatment: experience of a central London hospital Clin Rheumatol 30 2011 399 401
43. W.G. Dixon, K.L. Hyrich, K.D. Watson, M. Lunt, J. Galloway, and A. Ustianowski Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR) Ann Rheum Dis 69 2010 522 528
44. J.D. Mancuso, G.H. Mazurek, D. Tribble, C. Olsen, N.E. Aronson, L. Geiter, D. Goodwin, and L.W. Keep Discordance among commercially-available diagnostics for latent tuberculosis infection Am J Respir Crit Care Med 185 2012 427 434
45. S. Casas, A. Andreu, X. Juanola, X. Bordas, F. Alcaide, R. Moure, L. Anibarro, E. Cuchí, M. Esteve, V. Ortiz, M.R. Guerra, J. Rodríguez, D. Reina, G. Salvador, J. Guardiola, X. Surís, M.A. Pascual, C. Martí, X. Martínez-Lacasa, J. Cuquet, L. Gonzalez, and M. Santin Diagnosis of tuberculosis infection by tuberculin skin test and whole-blood interferon-gamma release assay in patients considered for anti-tumor necrosis factor-alpha therapy Diagn Microbiol Infect Dis 71 2011 57 65
46. C. Beglinger, J. Dudler, C. Mottet, D. Goodwin, and L.W. Keep Screening for tuberculosis infection before initiation of anti-TNF-α therapy Swiss Med Wkly 137 2007 621 622